NICOLE DAVISON: Open Payments
NPI 1194068650 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 100 payments from 15 companies in 2025. Trend: 2023 $85 · 2024 $498 · 2025 $1,859
Food & beverage: $1,859
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $388 |
| Corium, LLC | 11 | $226 |
| ABBVIE INC. | 10 | $215 |
| E.R. Squibb & Sons, L.L.C. | 13 | $187 |
| Lundbeck LLC | 12 | $186 |
| Alkermes, Inc. | 8 | $171 |
| Otsuka America Pharmaceutical, Inc. | 10 | $156 |
| Vanda Pharmaceuticals Inc. | 4 | $123 |
| Tris Pharma Inc | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
Products named: CAPLYTA, REXULTI, Azstarys, VRAYLAR, COBENFY, ARISTADA, FANAPT, Dyanavel XR.
Industry payments across MI — which companies pay providers there.
